Kato Y, Braunstein G D
Department of Medicine, Cedars-Sinai Medical Center-University of California School of Medicine, Los Angeles 90048.
J Clin Endocrinol Metab. 1988 Jun;66(6):1197-201. doi: 10.1210/jcem-66-6-1197.
A small mol wt fragment of the beta-subunit of hCG (beta-core fragment) is present in the urine, but not the serum, of pregnant women. We evaluated the relative proportions of this immunoreactive, but biologically inactive, fragment in urine from 15 women at different stages of pregnancy. Freshly voided urine was ultrafiltered and concentrated, and the molecular species of immunoreactive hCG were separated by Sephadex G-100 column chromatography. All urine samples contained the beta-core fragment, which eluted after the alpha-subunit of hCG. This fragment lacked the carboxy-terminal epitope of hCG, was inactive as an in vitro bioassay, and adsorbed to Concanavalin-A. The beta-core fragment was a major form the immunoreactive hCG in urine throughout pregnancy and accounted for over 90% of the immunoreactive hCG in urine from midpregnancy. The excretion pattern of the beta-core fragment can account for the low biological to immunological ratio of urinary hCG that occurs at different stages of pregnancy.
人绒毛膜促性腺激素β亚基的一个小分子量片段(β核心片段)存在于孕妇尿液中,而血清中没有。我们评估了15名处于不同孕期的女性尿液中这种具有免疫反应性但无生物活性的片段的相对比例。将新鲜排出的尿液进行超滤和浓缩,通过葡聚糖G - 100柱色谱法分离具有免疫反应性的人绒毛膜促性腺激素分子种类。所有尿液样本都含有β核心片段,其在人绒毛膜促性腺激素α亚基之后洗脱。该片段缺乏人绒毛膜促性腺激素的羧基末端表位,在体外生物测定中无活性,并能吸附到伴刀豆球蛋白A上。在整个孕期,β核心片段是尿液中具有免疫反应性的人绒毛膜促性腺激素的主要形式,在孕中期尿液中占免疫反应性人绒毛膜促性腺激素的90%以上。β核心片段的排泄模式可以解释孕期不同阶段尿液中人绒毛膜促性腺激素生物活性与免疫活性比例较低的现象。